ISSN 1308-7649 | E-ISSN 2148-3817
Instructions to Authors

 

 

The Journal of International Advanced Otology (IAO – Citation Abbreviation: J Int Adv Otol) is a open access, double-blind peer-reviewed, international publication. The Journal of International Advanced Otology is fully sponsored and owned by the European Academy of Otology and Neurotology and the Politzer Society. The journal is directed to an audience of physicians who are interested in both clinical and basic sciences.The Journal of International Advanced Otology publishes original articles in the form of clinical and basic research, review articles, short reports and a limited number of case reports. Controversial patient discussions, communications on emerging technology, and historical issues will also be considered for publication.

 

Editorial and publication processes of the journal are shaped in accordance with the guidelines of the international organizations such as the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE) , the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE)

 

The Journal of International Advanced Otology will only evaluate manuscripts submitted via the journal’s self-explanatory online manuscript submission and evaluation system, manuscripts submitted via any other medium will not be evaluated.

 

Previously published manuscripts (except in the form of an abstract or a preliminary report), and manuscripts that are under consideration for possible publication elsewhere will not be accepted for evaluation.

 

The Journal of International Advanced Otology requires each submission to be accompanied by a Copyright Transfer Form, an Author Contributions Form and an ICMJE Form for Disclosure of Potential Conflicts of Interest.

 

Statements or opinions expressed in the manuscripts published in the Journal of International Advanced Otology reflect the views of the author(s) and not the opinions of the editors, the editorial board and the publisher; the editors, the editorial board and the publisher disclaim any responsibility or liability for such materials.

 

The final responsibility in regard to the published articles rests with the authors.

 

Each individual listed as an author should fulfil the authorship criteria recommended by the International Committee of Medical Journal Editors (Uniform Requirements for Manuscripts Submitted to Biomedical Journals. http://www.icmje.org). Individuals who contributed to the preparation of the manuscript but do not fulfil the authorship criteria should be acknowledged in an acknowledgments section, which should be included in the title page of the manuscript.

 

The Journal of International Advanced Otology requires and encourages the authors and the individuals involved in the evaluation process to disclose any existing or potential conflicts of interests including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest.

 

All sources of funding should be acknowledged in the manuscript.

 

The authors should state in the Materials and Methods section of the main text that experiments have been performed in comply with the ethical principles of the assigned institutional board or national committee. Application or approval number/year for the study should also be indicated. For animal experiments, the authors additionally should state that international standards regarding the animal care and handling have been followed during the experiments.

 

It is the author’s responsibility to ensure that a patient’s anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. For photographs that may reveal the identity of the patients, signed releases of the patient or of his/her legal representative should be enclosed; otherwise, patient names or eyes must be  masked out to prevent identification.

 

When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration (JAMA 2000;284:3043–3049).

 

As part of submission of the manuscript, the correspondent author should send a short statement declaring that he/she accepts to undertake all the responsibility for authorship during the submission and review stages of the manuscript.

 

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication.

 

Manuscripts submitted to the journal will first go through a technical evaluation process where the editorial office staff will ensure that the manuscript is prepared and submitted in accordance with the journal’s guidelines. Submissions that don’t adhere the journal’s guidelines will be returned back to the submitting author with technical correction requests. Manuscripts that adhere the journal’s guidelines will be reviewed by at least 3 external peer reviewers during the evaluation process. The Editor in Chief is the final authority in the decision making process.

 

Authors of a paper accepted for publication in J Int Adv Otol should be in consent of that editors could make corrections without changing the basic meaning of the text of the manuscript.

 

The submitting authors will be automatically informed by the journal’s manuscript submission and evaluation system of any changes in the status of their submission.

 

MANUSCRIPT PREPARATION

Manuscripts should be prepared in accordance with the ICMJE - Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (updated in December 2016 – available at www.icmje.org). 

 

Original Investigations and Reviews should be presented according to the guidelines: randomized study – CONSORT, observational study – STROBE, study on diagnostic accuracy – STARD, systematic reviews and meta-analysis PRISMA, animal experimental studies – ARRIVE, nonrandomized behavioural and public health intervention studies – TREND.

 

Title page

A separate title page should be submitted with all submissions and should include the title of the manuscript, name(s), affiliations and major degree(s) of the author(s) and source(s) of the work or study, a short title (running head) of no more than 50 characters. The name, address, telephone (including the mobile phone number) and fax numbers and e-mail address of the corresponding author should be listed on the title page. Grant information and other sources of support should also be included on the Title page. Individuals who contributed to the preparation of the manuscript but do not fulfil the authorship criteria should be acknowledged in the title page.

 

Main Document

Abstract

All manuscripts should be accompanied an abstract. A structured abstract is required with original articles and it should include the following subheadings: Objective, Materials and Methods, Results and Conclusion. A structured abstract is not required with review articles and case reports. The abstract should be limited to 250 words for original articles and review articles and 150 words for case reports.

 

Key Words

Each submission should be accompanied by 3 to 5 key words which should be picked from the Medical Subject Headings (MeSH) list (www.nlm.nih.gov/mesh/MBrowser.html).

 

Main Text

The main text of Case Reports should be limited with 1200 words and should be structured with the following subheadings; Introduction, Case Presentation and Discussion. The maximum number of references cited in a case report should be 10.

 

The subheadings of the review articles should be planned by the authors. However, each review article should include a “Conclusion” section. The main text of review articles should be limited with 5000 words. The number of references cited should not exceed 50.

 

Original Articles should be structured with Introduction, Materials and Methods, Results subheadings Discussion. The number of references cited should not exceed 35 and the main text should be limited to 3000 words.

 

All acronyms and abbreviations used in the manuscript should be defined at first use, both in the abstract and the main text. The abbreviation should be provided in parenthesis following the definition.

 

Statistical analysis should be performed in accordance with guidelines on reporting statistics in medical journals (Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J 1983: 7; 1489-93.). Information on the statistical analysis process of the study should be provided within the main text.

 

When a drug, product, hardware, or software mentioned within the main text product information, including the name of the product, producer of the product, city of the company and the country of the company should be provided in parenthesis in the following format: “Discovery St PET/CT scanner (General Electric, Milwaukee, WI, USA)”

 

All references, tables and figures should be referred to within the main text and they should be numbered consecutively in the order they are referred to within the main text.

 

Limitations, drawbacks and shortcomings of original articles should be mentioned in the “Discussion” section before the conclusion paragraph.

 

References

References should be numbered consecutively in the order they are referred to within the main text and all references listed in the reference list should be referred to within the main text in parenthesis. Style and punctuation of each reference in the reference list should be in accordance with the examples listed below;

 

Standard journal article: Journal titles should be abbreviated in accordance with journal abbreviations used in Index Medicus (for journal abbreviations consult List of Journals indexed for MEDLINE published annually by NLM at http://www.nlm.nih.gov/tsd/serials/lji.html). When there are six or fewer authors, all authors should be listed. If there are seven or more authors, first 6 should be listed, followed by “et al.”. A list of authors should be followed by the full title of the article, journal title, year, volume and page numbers.

 

Example: Pirvola U, Xing-Qun L, Virkkala J, Saarma M, Murakata C, Camoratto AM, et al. Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation. J Neurosci 2000; 20: 43-50.

 

Books

Chapter in a book: Sherry S. Detection of thrombi. In: Strauss HE, Pitt B, James AE, editors. Cardiovascular Medicine. St Louis: Mosby; 1974.p. 273-85.

 

Personal author(s): Cohn PF. Silent myocardial ischemia and infarction. 3rd ed. New York: Marcel Dekker; 1993.

 

Editor(s), compiler(s) as author: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone; 1996.

 

Conference paper:

Bengisson S. Sothemin BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Rienhoff O, editors. MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sept 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. P. 1561-5.

 

Scientific or technical report:

Smith P. Golladay K. Payment for durable medical equipment billed during skilled nursing facility stays. Final report. Dallas (TX) Dept. of Health and Human Services (US). Office of Evaluation and Inspections: 1994 Oct. Report No: HHSIGOE 169200860.

 

Dissertation:

Kaplan SI. Post-hospital home health care: the elderly access and utilization (dissertation). St. Louis (MO): Washington Univ. 1995.

 

Article in electronic format:

Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis (serial online) 1995 Jan-Mar (cited 1996 June 5): 1(1): (24 screens). Available from: http:/ www.cdc.gov/ncidodlElD/cid.htm.

 

Tables 

Tables should be included in the main document and should be presented after the reference list. Tables should be numbered consecutively in the order they are referred to within the main text. A descriptive title should be provided for all tables and the titles should be placed above the tables. Abbreviations used in the tables should be defined below the tables by footnotes (even if they are defined within the main text). Tables should be created using the “insert table” command of the word processing software and they should be arranged clearly to provide an easy reading. Data presented in the tables should not be a repetition of the data presented within the main text but should be supporting the main text.

 

Figures and Figure Legends

Figures, graphics and photographs should be submitted as separate files (JPEG format) through the submission system. The files should not be embedded in a Word document or the main document. When there are figure subunits, the subunits should not be merged to form a single image. Each subunit should be submitted separately through the submission system. Images should not be labelled (a, b, c, etc.) to indicate figure subunits. Thick and thin arrows, arrowheads, stars, asterisks and similar marks can be used on the images to support figure legends. Like the rest of the submission, the figures too should be blind. Any information within the images that may indicate an individual or institution should be blinded. The minimum resolution of each submitted figure should be 300DPI. To prevent delays in the evaluation process all submitted figures should be clear in resolution and large in size (minimum dimensions 100x100mm)

 

Color figures: Authors who submit color figures will receive an estimate of the cost for color reproduction. Otherwise the figures will be converted to black and white.

 

Figure legends should be listed at the end of the main document. When there are figure subunits, the figure legends should be structured in the following format. 

 

Example: Figure 4. a-d. Effects of xylitol on viability of HMEECs and HEI-OC1s. Xylitol at concentrations of up to 1000 μg/mL did not decrease the viability of HMEECs and HEI-OC1s (a). Xylitol at concentrations of up to 1000 μg/mL did not induce apoptosis or necrosis of HMEECs and HEI-OC1s (b, c). Morphology of HMEECs and HEI-OC1s remained unchanged by xylitol at concentrations of up to 1000 μg/mL (light microscope, x200 and Hoechst 33342 staining, x400). The data shown are means±standard deviations of three repeated experiments from six samples (c, d)

 

Once a manuscript is accepted for publication it will be provided with a registered DOI number following the acceptance decision. Manuscripts accepted for publication by the Journal of International Advanced Otology will be published as ahead of print articles prior to the printing date of their scheduled issue. Corresponding author will be provided with a PDF Proof by the publisher once the production process of an accepted manuscript is over. The publisher will request the corresponding author to list their correction requests if there are any and approve the publication of the manuscript.

 

Subscription information

The access to all full-text issues of the journal is free at www.advancedotology.org. To become a member of the journal, please get in contact with the Editorial Office through jiao@advancedotology.org.

 

Permissions and Reprints

Permissions for reproduction of materials published and reprints in the Journal of International Advanced Otology should be requested from the editorial office at ozgirgin@politzersociety.org

Key Words
Authors
All
Author's Corner
Reviewer's Corner
Survey
AVES | Copyright © 2017 The European Academy of Otology and Neurotology | Latest Update: 26.05.2017